These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31934895)

  • 21. Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma.
    Mertens JC; Fingas CD; Christensen JD; Smoot RL; Bronk SF; Werneburg NW; Gustafson MP; Dietz AB; Roberts LR; Sirica AE; Gores GJ
    Cancer Res; 2013 Jan; 73(2):897-907. PubMed ID: 23221385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of Cholangiocarcinoma Immune Biology.
    Vita F; Olaizola I; Amato F; Rae C; Marco S; Banales JM; Braconi C
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholangiocarcinoma: what are the most valuable therapeutic targets - cancer-associated fibroblasts, immune cells, or beyond T cells?
    Wang J; Loeuillard E; Gores GJ; Ilyas SI
    Expert Opin Ther Targets; 2021 Oct; 25(10):835-845. PubMed ID: 34806500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-associated fibroblasts that restrain cancer progression: Hypotheses and perspectives.
    Miyai Y; Esaki N; Takahashi M; Enomoto A
    Cancer Sci; 2020 Apr; 111(4):1047-1057. PubMed ID: 32060987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vivo Models for Cholangiocarcinoma-What Can We Learn for Human Disease?
    Mohr R; Özdirik B; Knorr J; Wree A; Demir M; Tacke F; Roderburg C
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Tumor Microenvironment in Cholangiocarcinoma Progression.
    Fabris L; Sato K; Alpini G; Strazzabosco M
    Hepatology; 2021 Jan; 73 Suppl 1(Suppl 1):75-85. PubMed ID: 32500550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer-Associated Fibroblasts and Extracellular Matrix: Therapeutical Strategies for Modulating the Cholangiocarcinoma Microenvironment.
    Minini M; Fouassier L
    Curr Oncol; 2023 Apr; 30(4):4185-4196. PubMed ID: 37185432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma.
    Sha M; Jeong S; Qiu BJ; Tong Y; Xia L; Xu N; Zhang JJ; Xia Q
    Cancer Med; 2018 Sep; 7(9):4665-4677. PubMed ID: 30062820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Desmoplastic Tumor Microenvironment and Immunotherapy in Cholangiocarcinoma.
    Høgdall D; Lewinska M; Andersen JB
    Trends Cancer; 2018 Mar; 4(3):239-255. PubMed ID: 29506673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma.
    Zhang XF; Dong M; Pan YH; Chen JN; Huang XQ; Jin Y; Shao CK
    Hum Pathol; 2017 Jul; 65():92-100. PubMed ID: 28457731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy.
    Louis C; Edeline J; Coulouarn C
    Expert Opin Ther Targets; 2021 Feb; 25(2):153-162. PubMed ID: 33502260
    [No Abstract]   [Full Text] [Related]  

  • 32. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
    Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
    J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
    Pradip D; Jennifer A; Nandini D
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the function of stromal cells in cholangiocarcinoma by three-dimensional bioprinting immune microenvironment model.
    Li C; Jin B; Sun H; Wang Y; Zhao H; Sang X; Yang H; Mao Y
    Front Immunol; 2022; 13():941289. PubMed ID: 35983036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts.
    Raggi C; Invernizzi P; Andersen JB
    J Hepatol; 2015 Jan; 62(1):198-207. PubMed ID: 25220250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment.
    Bu L; Baba H; Yoshida N; Miyake K; Yasuda T; Uchihara T; Tan P; Ishimoto T
    Oncogene; 2019 Jun; 38(25):4887-4901. PubMed ID: 30816343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine Changes in Cholangiocarcinoma Growth.
    Sato K; Francis H; Zhou T; Meng F; Kennedy L; Ekser B; Baiocchi L; Onori P; Mancinelli R; Gaudio E; Franchitto A; Glaser S; Alpini G
    Cells; 2020 Feb; 9(2):. PubMed ID: 32069926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the Notch signaling in cholangiocarcinoma.
    Cigliano A; Wang J; Chen X; Calvisi DF
    Expert Opin Ther Targets; 2017 May; 21(5):471-483. PubMed ID: 28326864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression.
    Zhang Q; Lou Y; Bai XL; Liang TB
    World J Gastroenterol; 2018 Aug; 24(31):3500-3512. PubMed ID: 30131656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.
    Wu HJ; Chu PY
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.